Skip to main content
. 2022 Sep 30;611(7934):115–123. doi: 10.1038/s41586-022-05165-3

Fig. 3. Genomics-driven drug discovery.

Fig. 3

Overlap enrichment analysis using GREP22 (top). Middle, integrating MR results using cis- and trans-pQTLs as instrumental variables with data from drug databases. Bottom, negative correlation tests between compound-regulated gene expression profiles and genetically determined case–control gene expression profiles using Trans-Phar.